Medicare Enrolled
Dr. Vivek Roy, MD
Hematology & Oncology · Jacksonville, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Roy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Roy?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Roy
Dr. Vivek Roy is a hematology & oncology specialist in Jacksonville, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Roy performed 92,182 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Roy received a total of $6,907 from 10 pharmaceutical and/or device companies across 10 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Roy is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 8% volume in FL
$6,907 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 82048 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗92,182
Medicare services
Top 8% in FL for hematology & oncology
Not available
Unique patients (not deduplicated)
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Nivestym) for white blood cells An injection of the biosimilar medication filgrastim-aafi (Nivestym) at a dose of 1 microgram. |
13,200 | $0 | $1 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
11,220 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 11,202 | $41 | $195 |
| Anti-nausea injection (fosaprepitant) An injection of fosaprepitant, a medication used to prevent nausea and vomiting. |
7,200 | $0 | $1 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
6,560 | $2 | $11 |
| Daratumumab injection (Darzalex) An injection containing daratumumab and hyaluronidase-fihj administered under the skin. |
6,480 | $38 | $190 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
5,100 | $0 | $1 |
| Nivolumab injection (Opdivo) | 4,720 | $24 | $111 |
| Paclitaxel chemotherapy injection | 3,672 | $0 | $2 |
| Denosumab injection (Prolia/Xgeva) | 3,360 | $19 | $89 |
| Carfilzomib injection, 1 mg This code represents the administration of a 1 mg dose of carfilzomib via injection. |
1,910 | $36 | $174 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
1,890 | $35 | $137 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,780 | $0 | $4 |
| Bevacizumab-bvzr biosimilar injection, 10 mg An injection of bevacizumab-bvzr, a biosimilar medication, administered in a 10 mg dose. |
1,480 | $22 | $182 |
| Anti-nausea injection (ondansetron/Zofran) | 1,476 | $0 | $4 |
| Injection, durvalumab, 10 mg | 1,432 | $62 | $296 |
| Injection, docetaxel, 1 mg | 1,430 | $1 | $5 |
| Rituximab-pvvr biosimilar injection, 10 mg An injection of rituximab-pvvr, a biosimilar medication, administered in a 10 mg dose. |
1,250 | $22 | $194 |
| Bortezomib injection, 0.1 mg Administration of a 0.1 mg dose of bortezomib medication via injection. |
770 | $3 | $9 |
| Injection, atropine sulfate, 0.01 mg | 620 | $0 | $2 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
494 | $12 | $216 |
| Anti-nausea injection (Aloxi/palonosetron) | 340 | $1 | $9 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
302 | $101 | $869 |
| Injection, fulvestrant, 25 mg | 280 | $7 | $48 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
271 | $93 | $450 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
255 | $2 | $24 |
| Injection, irinotecan, 20 mg | 249 | $2 | $20 |
| Injection, leucovorin calcium, per 50 mg | 200 | $3 | $23 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 191 | $3 | $39 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
175 | $2 | $30 |
| Pegfilgrastim-jmdb injection An injection of pegfilgrastim-jmdb, a biosimilar medication. The dose specified is 0.5 mg. |
168 | $85 | $471 |
| Blood sample collection from implanted device This procedure involves drawing a blood sample directly from a medical device that has been surgically placed in the body. |
166 | $20 | $135 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 155 | $133 | $495 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
147 | $64 | $314 |
| Injection, potassium chloride, per 2 meq | 145 | $0 | $27 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
141 | $11 | $102 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
141 | $135 | $604 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
127 | $96 | $452 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
99 | $62 | $296 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
98 | $2 | $81 |
| Cisplatin chemotherapy injection, 10 mg Administration of a 10 mg dose of cisplatin, a chemotherapy medication, via injection. |
98 | $2 | $38 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
94 | $22 | $212 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
86 | $22 | $233 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
85 | $50 | $446 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
84 | $10 | $114 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
80 | $1 | $18 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
79 | $48 | $426 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
74 | $1 | $37 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
70 | $55 | $352 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
69 | $26 | $200 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
64 | $16 | $154 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
56 | $7 | $49 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
42 | $1 | $77 |
| Telephone or electronic consultation, at least 5 minutes A remote assessment and management service provided by a consulting physician via telephone, internet, or electronic health record. The service requires at least 5 minutes of time and includes a written report. |
38 | $26 | $105 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
37 | $15 | $143 |
| New patient office visit, complex (60-74 min) | 36 | $160 | $891 |
| IV chemotherapy initiation with community continuation Initiation of an intravenous chemotherapy infusion in a clinic using clinic supplies, with continuation of the infusion in a community setting such as home or assisted living. |
36 | $133 | $993 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
32 | $25 | $345 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
30 | $18 | $91 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
29 | $43 | $370 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
20 | $26 | $600 |
| Intravenous chemotherapy injection Chemotherapy medication is administered directly into a vein using a push technique. This method involves injecting the drug through a needle or catheter already placed in the vein. |
19 | $78 | $640 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
14 | $140 | $877 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
14 | $4 | $68 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
15.1% high complexity
83.5% medium
1.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,907
Total received (2019-2024)
Avg $1,151/year across 6 years
Top 42% in FL for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
10
Companies
10
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$265
2023
$3,317
2022
$525
2021
$525
2020
$158
2019
$2,118
Payments by company (2024)
Janssen Scientific Affairs, LLC
$150
PFIZER INC.
$115
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2019-2024) ›
Incyte Corporation
$3,300
AstraZeneca UK Limited
$2,055
BeiGene USA, Inc.
$525
BeiGene, Ltd.
$525
Janssen Scientific Affairs, LLC
$150
PFIZER INC.
$115
Astellas Pharma US Inc
$99
Akcea Therapeutics, Inc.
$63
Kite Pharma, Inc.
$59
CSL Behring
$17
Top 3 companies account for 85.1% of all-time payments
Associated products mentioned in payments ›
BRUKINSA · ELREXFIO · Kcentra · TALVEY · TEGSEDI · Yescarta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
104
County median income
$68,447
Nearest hospital to ZIP centroid (approximate)
MAYO CLINIC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Roy is a mixed practice specialist, with above-average Medicare volume (top 8% in FL), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Roy experienced with filgrastim injection (nivestym) for white blood cells?
Based on Medicare claims data, Dr. Roy performed 13,200 filgrastim injection (nivestym) for white blood cells services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Roy receive payments from pharmaceutical companies?
Yes. Dr. Roy received a total of $6,907 from 10 companies across 10 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Roy's costs compare to other hematology & oncology specialists in Jacksonville?
Dr. Roy's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Roy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Jacksonville
Browse hematology & oncology specialists in Jacksonville ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in FL
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in FL
Which FL hematology & oncology specialists receive the most from drug and device companies.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
By company
AstraZeneca UK Limited Payments to Doctors
See all physicians who received payments from AstraZeneca UK Limited.
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology